PURPOSE: The aim of this study was to determine the molecular genetic basis of an early-onset severe retinal dystrophy in three unrelated consecutive patients of Czech origin and to describe their ocular phenotype. METHODS: DNA samples from two probands were analyzed using a genotyping microarray (Asper) followed by either target analysis of 43 genes implicated in retinal disorders by next generation sequencing or whole-exome sequencing, respectively. The third proband underwent conventional Sanger sequencing of CRB1 based on her ocular findings. RESULTS: All three probands harboured a known disease-causing mutation c.2843G>A; p.(Cys948Tyr) in the CRB1 gene. One individual was homozygous for this mutation, while in the other two probands c.2308G>A; p.(Gly770Ser) and c.3121A>G; p.(Met1041Val) were also identified in the heterozygous state, respectively. Both variants were novel and evaluated by in silico analysis as pathogenic. A false-negative result was observed in one of the two samples examined by the genotyping microarray. Disease onset in all patients was before the age of 7 years. Hypermetropic refractive error, bilateral nummular retinal pigmentation, retinal thickening and cystoid spaces in the macula were observed in two probands, aged 6 and 7 years. The third proband, aged 28 years, had bone spicule-like pigmentary changes associated with increased retinal nerve fiber layer. CONCLUSIONS: The first study reporting on the molecular genetic cause of non-syndromic early-onset severe retinal dystrophy in Czech patients identified one homozygous and two compound heterozygote probands with CRB1 mutations. Retina nerve fibre layer measurements should be considered an integral part of the clinical evaluation of retinal dystrophies. Detailed clinical examination and imaging can both direct molecular screening and help to confirm or refute disease causation of identified variants.

Department of Genetics Faculty Hospital Brno Czech Republic

Department of Ophthalmology 1st Faculty of Medicine Charles University Prague and General University Hospital Prague Prague Czech Republic

GENNET Prague Czech Republic

Institute of Inherited Metabolic Disorders General Teaching Hospital and 1st Faculty of Medicine Charles University Ke Karlovu 2 Praha 2 128 08 Prague Czech Republic

Moorfields Eye Hospital NHS Foundation Trust London UK

UCL Institute of Ophthalmology London UK

Zobrazit více v PubMed

World J Clin Cases. 2015 Feb 16;3(2):112-24 PubMed

J Mol Biol. 2000 Sep 8;302(1):205-17 PubMed

Hum Mol Genet. 2003 May 1;12(9):1073-8 PubMed

Nat Methods. 2014 Apr;11(4):361-2 PubMed

Am J Ophthalmol. 2010 Apr;149(4):651-655.e2 PubMed

Clin Genet. 2013 Aug;84(2):132-41 PubMed

Hum Genet. 2001 Jul;109(1):121-4 PubMed

PLoS One. 2012;7(10):e46688 PubMed

Nat Methods. 2010 Apr;7(4):248-9 PubMed

Hum Mutat. 2016 Jun;37(6):564-9 PubMed

Lancet. 2006 Nov 18;368(9549):1795-809 PubMed

Am J Ophthalmol. 2014 Sep;158(3):567-73.e2 PubMed

Hum Mutat. 2009 Aug;30(8):1237-44 PubMed

Invest Ophthalmol Vis Sci. 2011 Jan 05;52(1):292-302 PubMed

Ophthalmic Genet. 2015;36(3):257-64 PubMed

Ophthalmic Genet. 2011 Sep;32(3):165-74 PubMed

Nat Protoc. 2009;4(7):1073-81 PubMed

Bioinformatics. 2009 Nov 1;25(21):2744-50 PubMed

Prog Retin Eye Res. 2008 Jul;27(4):391-419 PubMed

Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5684-9 PubMed

Cesk Slov Oftalmol. 2014 Dec;70(6):228-33 PubMed

Hum Mutat. 2012 Feb;33(2):306-15 PubMed

Br J Ophthalmol. 2011 Jun;95(6):811-7 PubMed

Curr Eye Res. 2009 May;34(5):395-400 PubMed